These important findings on esketamine nasal spray as a treatment for young individuals with suicidal ideation were presented at the ACNP 2023 Annual Meeting. We interviewed the vice president and head of neuropsychiatry clinical development at Johnson & Johnson Innovative Medicine to learn more.
Is love blind? A psychiatrist analyzes the viral reality tv experiment.
Andrew Krystal, MD, and Wayne Drevets, MD, share their thoughts on the recent seltorexant data presented at the 2024 ASCP Annual Meeting.
Brain Capital: a fresh approach to technologies and investing.
What happens when patients receive special treatment based on their rank or relationships? Two survivors share their stories.
There are several points along this pathway for a justice involved patient to be intercepted and diverted to mental health treatment.
D-cycloserine may help patients with anxiety disorders, or it might make their anxiety worse. Find out how to use it safely.
While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.
How can looking at the suffering of patients with schizophrenia through a psychodynamic lens help clinicians develop effective interventions and treatment plans?
“The mere legalization of MAID creates a serious and discriminatory danger…”
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
In approximately half of patients with Huntington disease, symptoms of depression, irritability/aggression, executive dysfunction, psychosis, cognitive decline, and dementia present long before progressive motor symptoms.
The authors share evidence-based guidance for patient safety that minimizes suicide risk in medical settings.
The COVID-19 pandemic has disproportionately affected people of color due to legal, social, and economic inequities.
Bisexual individuals are at 4.5 to 6 higher risk of self harming than heterosexual individuals, according to this online study.
What are the connections between what we eat and disorders such as anxiety and depression?
In the final episode of this series, the experts share their conclusions and why examining the human side of fraud—in addition to the instruments of fraud—is key.
Effective coordination of EHR system data between youth justice facilities and reentry programs can play a pivotal role in a youth’s successful reintegration into the community.
In this custom video series, Debra Stultz, MD, and Haramandeep Singh, MD, share advice for community-based psychiatrists on the management of narcolepsy.
This article provides a summary of key points discussed in a Case-Based Psych Perspectives Series, shared by Bryce Reynolds, MD, and Hannah Phillips-Hall, MSN, PMHNP-BC.
For older adults, hoarding disorder can have serious consequences. Examine this case study to learn more.
Cannabis use during pregnancy is associated with a host of negative outcomes.
The ambiguity of psychiatry naturally lends itself to a story, and creativity is all about telling a story.
A recent study serves as a model for future studies and lists several implications for the future of climate change psychiatric research.
In this CME article, learn more about the controversies surrounding Lyme disease diagnosis and treatment, and common neuropsychiatric presentations of and treatment options.
Lessons from the opioid epidemic should be applied to cases of methamphetamine abuse.
In this CME article, learn more about the full continuum of presentations and variable trajectories typical of females with ADHD.
The use of validated and scalable risk prediction tools can potentially improve mental health outcomes.